Ulu E M K, Tutar N U, Coskun M, Tore H G, Guvenc Z, Haberal M
Department of Radiology, Baskent University Faculty of Medicine, Ankara, Turkey.
Transplant Proc. 2007 May;39(4):1066-70. doi: 10.1016/j.transproceed.2007.02.025.
Incidence of malignancy in solid organ transplant recipients is higher compared to the general population. The aim of this study was to characterize distribution and appearance of abdominal malignant tumors detected with spiral computed tomography (CT) examination in patients with solid organ transplantation.
Between July 1994 and April 2006, 198 patients underwent liver transplantation and 568 patients underwent renal transplantation in our center. The abdominal CT studies were reviewed to determine the presence or absence of abdominal malignancy. All abdominal CT examinations were performed prior to immunomodulation or chemotherapy.
Eleven renal and one liver transplantation patient developed an abdominal malignancy. Among 11 renal transplantation patients eight were diagnosed as abdominal Kaposi's sarcoma (KS) and three as posttransplantation lymphoproliferative disorder (PTLD) upon spiral CT examination. In two patients the transplanted organ itself had malignant tumors: one patient had PTLD with Burkitt lymphoma in the transplanted liver and the other a renal cell carcinoma in the transplanted kidney. Abdominal PTLD and KS showed imaging findings and the site of organ involvement somewhat different from nontransplant patients. The most common pathologies in KS were liver lesions (n=6) and lymphadenopathy (n=6). But in abdominal PTLD, the spleen (n=3) was the most involved organ.
The early diagnosis of abdominal malignancies after solid organ transplantation is crucial for the patient's prognosis, especially under immunosuppression. The abdominal spiral CT examination was an effective modality to depict a malignancy among patients with solid organ transplantation.
与普通人群相比,实体器官移植受者发生恶性肿瘤的几率更高。本研究的目的是描述实体器官移植患者通过螺旋计算机断层扫描(CT)检查发现的腹部恶性肿瘤的分布和表现。
1994年7月至2006年4月期间,本中心有198例患者接受了肝移植,568例患者接受了肾移植。回顾腹部CT研究以确定是否存在腹部恶性肿瘤。所有腹部CT检查均在免疫调节或化疗之前进行。
11例肾移植患者和1例肝移植患者发生了腹部恶性肿瘤。在11例肾移植患者中,8例经螺旋CT检查诊断为腹部卡波西肉瘤(KS),3例诊断为移植后淋巴细胞增生性疾病(PTLD)。2例患者的移植器官本身存在恶性肿瘤:1例患者移植肝中有伴伯基特淋巴瘤的PTLD,另1例患者移植肾中有肾细胞癌。腹部PTLD和KS的影像学表现及器官受累部位与非移植患者略有不同。KS最常见的病理表现为肝脏病变(n = 6)和淋巴结病(n = 6)。但在腹部PTLD中,脾脏(n = 3)是最常受累的器官。
实体器官移植后腹部恶性肿瘤的早期诊断对患者的预后至关重要,尤其是在免疫抑制状态下。腹部螺旋CT检查是描绘实体器官移植患者恶性肿瘤的有效方法。